Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS

• Sponsor: Muhimbili University of Health and Allied Sciences (Other)
• Overall Status: Completed
• CT.gov ID: NCT05786703
• Collaborator: (none)
• Enrollment: 333
• Location: 1
• Actual Duration (Months): 5.9
• Patients Per Site Per Month: 56

Study Details

Study Description

Brief Summary

This project was a facility-based program intervention for PLHIV aged 18 years and above who attended a CTC in Dar es Salaam, Tanzania. Clients received preventive, diagnostic and treatment services for HTN and T2DM. The primary health outcomes was all-cause mortality, disease-specific morbidity, HTN and T2DM control rates. Secondary outcomes included access to care, retention in care adherence and quality of care. Results obtained can be used to strengthen NCDs care delivery in HIV/AIDS care in CTC in Tanzania.

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus; Hypertension; HIV Infections	Diagnostic Test: Biochemical, weight measurements, Blood pressure and blood sugar level

Detailed Description

A cohort of patients who were diagnosed with hypertension and diabetes was created and followed up for 6 months. Patients were be required to attend clinics on a monthly basis. At first visit short interview using the STEPwise approach of the STEPS surveillance tool for NCDs from the WHO was be conducted. On subsequent visits, hypertension and blood sugar level and cholesterol levels will be measured and adherence to medication were assessed. The patient's registry was developed following recommendation from the HEARTS technical package of World Health Organization (WHO) with some modification if needed. A simple surveillance system was developed for all patients diagnosed with hypertension and diabetes so that there is continuous evaluation and monitoring of all patients attending NCDs care at HIV clinic.

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 333 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS Attending Care and Treatment Center in Dar es Salaam, Tanzania
• Actual Study Start Date: Jan 1, 2020
• Actual Primary Completion Date: Jun 30, 2020
• Actual Study Completion Date: Jun 30, 2020

Outcome Measures

Primary Outcome Measures

1. CHANGE IN BLOOD PRESSURE LEVEL [SIX MONTHS]

   Change in the mean blood pressure at the beginning and the end of the study

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 54 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

All PLHIV who attended CTC 18 years and above

Exclusion Criteria:

• Pregnant women living with HIV/AIDS

• Patients with mental diseases.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Temeke Regional Referral Hospital	Dar Es Salaam		Tanzania

Sponsors and Collaborators

• Muhimbili University of Health and Allied Sciences

Investigators

• Principal Investigator: Atuganile Musyani, Masters, Muhimbili University of Health and Allied Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Atuganile Musyani, Principal Investigator, Muhimbili University of Health and Allied Sciences
• ClinicalTrials.gov Identifier: NCT05786703
• Other Study ID Numbers: MUHAS-REC-1-2020-074
• First Posted: Mar 27, 2023
• Last Update Posted: Mar 27, 2023
• Last Verified: Mar 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Hypertension; Diabetes Mellitus; Diabetes Mellitus, Type 2

Study Results

No Results Posted as of Mar 27, 2023